Israel Leads a World First: Bioengineered Spinal Cord Implant

[:en] In a world-first for regenerative medicine, surgeons in Israel will soon implant a bioengineered, personalized human spinal cord into a paralyzed patient – using tissue grown from the patient’s own cells . The unprecedented procedure aims to enable the patient, who today relies on a wheelchair, to stand up and walk again. Announced by Tel Aviv University and Israeli biotech startup Matricelf, this landmark effort is more than just a medical experiment; it’s a powerful illustration of Israel’s innovation ecosystem at work, bridging cutting-edge academia and industry to transform lives on a global stage. “This is undoubtedly a matter of national pride,” says Professor Tal Dvir of Tel Aviv University, who led the research team. “The technology was developed here in Israel… and from the very beginning it was clear to us that the first-ever surgery would be performed in Israel, with an Israeli patient”. Indeed, Israel’s Health Ministry gave special approval for “compassionate use” trials in a handful of paralyzed patients, ensuring that the very first human to receive this implant will be treated at home in Israel . For a country often dubbed the “Startup Nation,” this moment signifies a new chapter – one where Israeli science turns early lab breakthroughs into hopeful therapies, with the world watching. How to Grow a New Spinal Cord from Patient’s Cells Illustration: Tel Aviv University researchers outline the envisioned procedure for treating paralysis with a personalized spinal cord implant, grown from the patient’s own cells (Tel Aviv University/Matricelf). What sounds like science fiction is becoming reality. Israeli scientists have created a process to regrow a spinal cord from a patient’s own cells : Cell Collection : Doctors take a small blood and fat sample. Reprogramming : The cells are turned into stem cells able to become any tissue. Scaffold Creation : Molecules from the patient’s fat are used to make a hydrogel scaffold, minimizing rejection risk. Tissue Engineering : Stem cells grow in the hydrogel, forming spinal cord tissue with neurons. Implantation : Surgeons replace scar tissue at the injury site with the engineered cord, hoping it reconnects signals. In preclinical trials, 80–100% of paralyzed rats walked again after receiving the implant [2] [3] . “Our goal is to help paralyzed patients rise from their wheelchairs,” says Prof. Tal Dvir , who leads the project. The first human procedure, approved under compassionate use, will treat one patient at a time. Regulators have authorized up to eight participants . If successful, the first implant could change not only one life, but the entire outlook on treating paralysis. A New Hope for Paralyzed Patients For the 15 million people worldwide living with spinal cord injuries , the stakes are enormous. A severed spine has long meant permanent paralysis — damaged nerves do not regenerate, and scar tissue often blocks any chance of reconnection . Medicine has offered little beyond wheelchairs, prosthetics, or rehabilitation to improve quality of life. The Israeli team’s approach is different: it seeks not just to manage symptoms, but to heal the injury by regrowing the patient’s own spinal cord tissue . “We are hopeful that the results in humans will be just as promising,” says Prof. Tal Dvir . Even partial recovery - a return of movement or sensation - would change the outlook for patients and families who had lost hope. A key to success is personalization. By using each patient’s own cells, the risk of immune rejection is minimized, making the body far more likely to accept the implant . “Our approach… eliminates key safety risks,” explains Matricelf CEO Gil Hakim . In this model, the patient is both donor and recipient - a powerful example of personalized medicine and part of a wider regenerative trend toward tailor-made therapies. Part of a Bigger Trend in Israeli Biotech This spinal cord implant is ambitious, but not isolated. It reflects a decade of Israeli breakthroughs in regenerative and personalized medicine . In 2019, Prof. Tal Dvir’s team at Tel Aviv University 3D-printed the world’s first tiny heart using a patient’s own cells - a milestone that foreshadowed today’s spinal cord project. Other startups have pushed similar frontiers. Bonus BioGroup grew bone grafts from patients’ fat cells and transplanted them back - the first such procedure worldwide. Across Israel, labs are testing lab-grown corneas, personalized cancer vaccines, and more. This wave is powered by collaboration: universities, hospitals, and startups working side by side, with regulators showing unusual agility. In this case, the Health Ministry approved compassionate-use surgery , balancing caution with innovation. Such efforts reveal how Israel’s “Startup Nation” is evolving into a “Healing Nation” - where high-tech meets biotech to tackle the hardest medical challenges. A Milestone for Global Medicine If a paralyzed patient soon walks thanks to a lab-grown spinal cord, the impact will be global. Success would not only offer hope but could define a new standard of care and spark an industry in spinal regeneration . It also highlights Israel’s outsized role in global health. The spinal cord project began in a university lab, was scaled by a startup, approved by regulators, and is now inspiring the world. For Israel Valley Santé, it exemplifies our mission: showing how bold ideas in Israel can bridge science, entrepreneurship, and global impact. Whether the first patient walks again or not, a once-unthinkable door has opened. This is more than medicine - it’s a story of imagination, perseverance, and the innovative spirit Israel Valley Santé is here to celebrate. Sources: [1] Tel Aviv University / AFTAU – “Surgeons to implant spinal cord bioengineered at TAU” (Aug. 20, 2025) 👉 Read here [2] EurekAlert! (Tel Aviv University) – “The first human spinal cord repair using the patient’s own cells” (Aug. 20, 2025) 👉 Read here [3] Times of Israel – “In world 1st bid to cure paralysis, Israeli team gears up to implant innovative spinal cord” (Aug. 21, 2025) 👉 Read here [4] Times of Israel – “Israeli scientists unveil world’s first 3D-printed heart with human tissue” (2019) 👉 Read here [5] Reuters – “Israel’s Bonus says lab-grown bones successfully transplanted” (Dec. 5, 2016) 👉 Read here [:]

Israel Leads a World First: Bioengineered Spinal Cord Implant

From Tel Aviv University labs to the operating room, Israeli scientists and startups are pioneering regenerative medicine.

Brouillon auto

Subscribe.

New Book Release – Israel Valley: The Technology Shield of Innovation

Medical Breakthrough in Israel: Brain Surgery Through the Eye Socket

Decibel extends the international footprint of its General Admission brand

France–Israel: Accelerating Healthcare Innovation Through Artificial Intelligence

Next Gen Diagnostics and the Sheba Medical Center will sequence and analyze highly resistant bacterial infections.

Violent success with an anti-obesity drug in Israel, Wegovy.

Israel. A new type of nanoparticles that will treat specific types of cancer.

Radio J. Tsahal heals his wounded thanks to very innovative solutions. A prototype human heart printed in 3D. Nanox, medical imaging technology.

Brouillon auto

Brouillon auto

Nouvelle parution – Israel Valley : Le Bouclier technologique de l’innovation

France-Israël : Accélérer l’innovation en santé grâce à l’intelligence artificielle

Navigate Site

Israel Leads a World First: Bioengineered Spinal Cord Implant

From Tel Aviv University labs to the operating room, Israeli scientists and startups are pioneering regenerative medicine.

Subscribe.

Navigate Site

Follow Us

En savoir plus sur